Also published in GlobeNewswire:
NACD Directorship 100 Forum Focused on Reinvigorating America
x hide permanently

TRACON Pharmaceuticals Appoints Stephen Worland to Its Board of Directors

GlobeNewswire

SAN DIEGO, Feb. 27, 2015 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular ...

Mentions: CEO Board of Directors